SYNERGISTIC ANTITUMOR EFFECTS OF A COMBINED THERAPY CONSISTING OF IMMUNE CHECKPOINT INHIBITORS AND TUMOR-TARGETING NANOPARTICLES IN GLIOBLASTOMA

被引：0
|
作者：
Shevtsov, M. [1 ,2 ]
Stangl, S. [1 ]
Nikolaev, B. [3 ]
Edmond, S. [1 ,4 ]
Yakovleva, L. [3 ]
Marchenko, Y. [3 ]
Ryzhov, V. [5 ]
Margulis, B. [6 ]
Pitkin, E. [7 ]
Multhoff, G. [1 ]
机构：
[1] Tech Univ Munich, Munich, Germany
[2] UCL, UCL Canc Inst, London, England
[3] Res Inst Highly Pure Biopreparat, St Petersburg, Russia
[4] St Gerards Catholic Hosp, Kaduna, Nigeria
[5] Petersburg Nucl Phys Inst, NRC Kurchatov Inst, Gatchina, Russia
[6] RAS, Inst Cytol, St Petersburg, Russia
[7] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA
来源：
NEURO-ONCOLOGY | 2018年 / 20卷
基金：
俄罗斯科学基金会;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P04.01
引用
收藏
页码：277 / 278
页数：2
相关论文
共 50 条
  • [1] Long circulation and tumor-targeting biomimetic nanoparticles for efficient chemo/photothermal synergistic therapy
    Zhang, Yifan
    Yue, Xuanyu
    Yang, Shengchao
    Li, Xianglong
    Cui, Lin
    Cui, Xiaobin
    Shi, Yue
    Liu, Zhiyong
    Guo, Xuhong
    Li, Yongsheng
    JOURNAL OF MATERIALS CHEMISTRY B, 2022, 10 (26) : 5035 - 5044
  • [2] Prospect of Immunotherapy for Glioblastoma: Tumor Vaccine, Immune Checkpoint Inhibitors and Combination Therapy
    Ishikawa, Eiichi
    Yamamoto, Tetsuya
    Matsumura, Akira
    NEUROLOGIA MEDICO-CHIRURGICA, 2017, 57 (07) : 321 - 330
  • [3] Immunovirotherapy Combined with Immune Checkpoint Inhibitors for Treating Glioblastoma
    Saha, Dipongkor
    Martuza, Robert L.
    Rabkin, Samuel D.
    MOLECULAR THERAPY, 2015, 23 : S248 - S248
  • [4] Antiangiogenic antibody BD0801 combined with immune checkpoint inhibitors achieves synergistic antitumor activity and affects the tumor microenvironment
    Xue, Liting
    Gao, Xingyuan
    Zhang, Haoyu
    Tang, Jianxing
    Wang, Qian
    Li, Feng
    Li, Xinxin
    Yu, Xiaohong
    Lu, Zhihong
    Huang, Yue
    Tang, Renhong
    Yang, Wenqing
    BMC CANCER, 2021, 21 (01)
  • [5] Antiangiogenic antibody BD0801 combined with immune checkpoint inhibitors achieves synergistic antitumor activity and affects the tumor microenvironment
    Liting Xue
    Xingyuan Gao
    Haoyu Zhang
    Jianxing Tang
    Qian Wang
    Feng Li
    Xinxin Li
    Xiaohong Yu
    Zhihong Lu
    Yue Huang
    Renhong Tang
    Wenqing Yang
    BMC Cancer, 21
  • [6] Synergistic Effects of Fruquintinib Combined with Immune Checkpoint Inhibitors on Metastatic Colorectal Cancer
    Xie, Ming-zhi
    Li, Yong-qiang
    Liang, Rong
    Huang, Shi-ying
    Qin, Shan-yu
    Hu, Bang-li
    JOURNAL OF GASTROINTESTINAL CANCER, 2024, 55 (04) : 1620 - 1627
  • [7] Tumor-targeting and hyaluronidase activatable nanoparticles for tumor tracer and photochemistry therapy
    Li, Wenjun
    Pan, Zhengyin
    Zheng, Cuifang
    Liu, Peng
    Zhang, Pengfei
    Cai, Lintao
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2016, 12 (02) : 569 - 569
  • [8] Dual-Functionalized Janus Mesoporous Silica Nanoparticles with Active Targeting and Charge Reversal for Synergistic Tumor-Targeting Therapy
    Liu, Yajun
    Dai, Rui
    Wei, Quyu
    Li, Wenzhe
    Zhu, Guang
    Chi, Hao
    Guo, Zhaoming
    Wang, Li
    Cui, Changhao
    Xu, Jianqiang
    Ma, Kun
    ACS APPLIED MATERIALS & INTERFACES, 2019, 11 (47) : 44582 - 44592
  • [9] Enhancing tumor-targeting monoclonal antibodies therapy by PARP inhibitors
    Yelamos, Jose
    Galindo, Miguel
    Navarro, Judith
    Albanell, Joan
    Rovira, Ana
    Rojo, Federico
    Oliver, Javier
    ONCOIMMUNOLOGY, 2016, 5 (01):
  • [10] Genetically engineered bacteria-mediated multi-functional nanoparticles for synergistic tumor-targeting therapy
    Wang, Yaotai
    Tang, Yu
    Du, Yan
    Lin, Li
    Zhang, Zhong
    Ou, Xia
    Chen, Sheng
    Wang, Qi
    Zou, Jianzhong
    ACTA BIOMATERIALIA, 2022, 150 : 337 - 352
12345